QPS Selects Oracle Argus Safety to Strengthen Pharmacovigilance in Clinical Trials

QPS Holdings, LLC, an award-winning contract research organisation focused on clinical trials and bioanalysis, has implemented the Oracle Argus Safety Database to elevate its pharmacovigilance capabilities. This industry-leading safety case management system will support QPS in capturing, managing and reporting adverse event data across clinical trials with greater efficiency and compliance. By adopting Argus, QPS aims to improve patient safety oversight, strengthen regulatory compliance and streamline safety reporting workflows for sponsors.

The move reflects QPS’s commitment to operational excellence and advanced technology integration as drug development becomes increasingly complex and data-intensive. Oracle Argus is widely recognised as a comprehensive pharmacovigilance solution that enables systematic processing of safety cases, facilitates regulatory submissions and supports global safety signal detection. Its scalability and robust framework help ensure that safety data from trials are reliably handled from initial case intake through to final reporting. With Argus now in place, QPS is positioned to offer enhanced safety services that align with evolving regulatory expectations.